Could Toxicity Issues Topple CAR-T Cancer Therapies?
August 27, 2016 at 11:42 AM EDT
After deadly clinical trials, should investors fear safety issues might further delay or even topple CAR-T therapies and stocks?
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.